InvestorsHub Logo
Followers 1
Posts 10
Boards Moderated 0
Alias Born 03/15/2021

Re: None

Tuesday, 07/12/2022 1:06:11 PM

Tuesday, July 12, 2022 1:06:11 PM

Post# of 16697
Algernon Pharmaceuticals provides update on chronic kidney disease research program with NP-251

Just saw this video on ticker "AGNPF" and after doing some quick DD I'm shocked to see this at only a $4.6M USD valuation with so many irons in the fire. A biotech company at such an absurdly low market cap should be multiples higher just on their IP alone. 

Anyone else watch this? Up 6% today